{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:05:50Z","timestamp":1791345950435,"version":"4.3.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ejpb.2013.03.006","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T07:17:29Z","timestamp":1364282249000},"page":"862-872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"PB","title":["Design of pH responsive clickable prodrugs applied to histone deacetylase inhibitors: A new strategy for anticancer therapy"],"prefix":"10.1016","volume":"85","author":[{"given":"R\u00e9gis","family":"Delatouche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iza","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Grinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima El","family":"Bahhaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Baucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floraine","family":"Collette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"H\u00e9roguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Blanquart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2013.03.006_b0005","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.taap.2010.03.022","article-title":"Molecular targets of epigenetic regulation and effectors of environmental influences","volume":"245","author":"Choudhuri","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejpb.2013.03.006_b0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrg2206","article-title":"Nucleosome destabilization in the epigenetic regulation of gene expression","volume":"9","author":"Henikoff","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejpb.2013.03.006_b0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrg1349","article-title":"Epigenomics: beyond CpG islands","volume":"5","author":"Fazzari","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejpb.2013.03.006_b0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cbic.201000474","article-title":"Dynamic interplay between histone H3 modifications and protein interpreters: emerging evidence for a \u201chistone language\u201d","volume":"12","author":"Oliver","year":"2011","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ejpb.2013.03.006_b0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg816","article-title":"The fundamental role of epigenetic events in cancer","volume":"3","author":"Jones","year":"2002","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejpb.2013.03.006_b0030","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.drudis.2009.06.008","article-title":"Histone acetyl transferases as emerging drug targets","volume":"14","author":"Dekker","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2013.03.006_b0035","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.ejmech.2010.02.030","article-title":"Inside HDAC with HDAC inhibitors","volume":"45","author":"Bertrand","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejpb.2013.03.006_b0040","doi-asserted-by":"crossref","unstructured":"D.S. Hewings, T.P.C. Rooney, L.E. Jennings, D.A. Hay, C.J. Schofield, P.E. Brennan, S. Knapp, S.J. Conway, Progress in the development and application of small molecule inhibitors of bromodomain\u2013acetyl-lysine interactions, J. Med. Chem. http:\/\/dx.doi.org\/10.1021\/jm300915b.","DOI":"10.1021\/jm300915b"},{"key":"10.1016\/j.ejpb.2013.03.006_b0045","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"27","author":"Lane","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2013.03.006_b0050","first-page":"117","article-title":"Interpreting clinical assays for histone deacetylase inhibitors","volume":"3","author":"Martinet","year":"2011","journal-title":"Cancer Manage. Res."},{"key":"10.1016\/j.ejpb.2013.03.006_b0055","first-page":"4916","article-title":"FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases","volume":"62","author":"Furumai","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2013.03.006_b0060","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpba.2006.05.005","article-title":"Stability studies of vorinostat and its two metabolites in human plasma, serum and urine","volume":"42","author":"Du","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2013.03.006_b0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jchromb.2006.04.044","article-title":"A liquid chromatography\u2013electrospray ionization tandem mass spectrometric assay for quantitation of the histone deacetylase inhibitor, vorinostat (suberoylanilide hydroxamicacid, SAHA), and its metabolites in human serum","volume":"840","author":"Parise","year":"2006","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ejpb.2013.03.006_b0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/CAD.0b013e3283262a32","article-title":"Acquired vorinostat resistance shows partial cross-resistance to \u2018second-generation\u2019 HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities","volume":"20","author":"Dedes","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ejpb.2013.03.006_b0075","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/rcm.976","article-title":"Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the blood","volume":"17","author":"Xiao","year":"2003","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ejpb.2013.03.006_b0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1248\/bpb.28.124","article-title":"Identification of cytochrome P450 enzymes involved in the metabolism of FK228, a potent histone deacetylase inhibitor, in human liver microsomes","volume":"28","author":"Shiraga","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2013.03.006_h0080","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1158\/1078-0432.CCR-05-1423","article-title":"Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176)","volume":"12","author":"Robey","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejpb.2013.03.006_h0085","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/jpet.104.072033","article-title":"Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1","volume":"313","author":"Xiao","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejpb.2013.03.006_b0090","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature08910","article-title":"The endocytic matrix","volume":"463","author":"Scita","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2013.03.006_h0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1021\/bc960038u","article-title":"Novel acid labile COL1 trityl-linked difluoronucleoside immunoconjugates: synthesis, characterization, and biological activity","volume":"7","author":"Patel","year":"1996","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejpb.2013.03.006_h0100","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1016\/0040-4020(95)00137-W","article-title":"Heterobifunctional trityl derivatives as linking reagents for the recovery of nucleic acids after labeling and immobilization","volume":"51","author":"Leikauf","year":"1995","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejpb.2013.03.006_b0100","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1021\/bc049853x","article-title":"Acetals as pH-sensitive linkages for drug delivery","volume":"15","author":"Fr\u00e9chet","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejpb.2013.03.006_h0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2004.11.017","article-title":"Polymeric micellar pH-sensitive drug delivery system for doxorubicin","volume":"103","author":"Hruby","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2013.03.006_h0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2011.02.005","article-title":"Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker","volume":"152","author":"Kaminskas","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2013.03.006_b0110","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1021\/nn200007z","article-title":"Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells","volume":"5","author":"Wang","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2013.03.006_h0125","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1021\/jo070131j","article-title":"Click chemistry with O-dimethylpropargylcarbamate for preparation of pH-sensitive functional groups. a case study","volume":"72","author":"Bertrand","year":"2007","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejpb.2013.03.006_h0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tet.2010.11.026","article-title":"Novel triazolyl derivatives for acidic release of amines","volume":"67","author":"Delatouche","year":"2011","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejpb.2013.03.006_h0135","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/ejoc.201001677","article-title":"Triazolyl derivatives for acidic release of alcohols","author":"Mondon","year":"2011","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejpb.2013.03.006_h0140","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1055\/s-0031-1289719","article-title":"Extending triazolyl-based release under mildly acidic conditions to give aniline derivatives","volume":"44","author":"Delatouche","year":"2012","journal-title":"Synthesis"},{"key":"10.1016\/j.ejpb.2013.03.006_h0145","doi-asserted-by":"crossref","first-page":"10824","DOI":"10.1021\/ja052280u","article-title":"Promotion of proton conduction in polymer electrolyte membranes by 1H-1,2,3-triazole","volume":"127","author":"Zhou","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejpb.2013.03.006_h0150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1476-5381.2009.00288.x","article-title":"Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers","volume":"157","author":"Midoux","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2013.03.006_h0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2008.05.003","article-title":"Recent progress in tumor pH targeting nanotechnology","volume":"132","author":"Lee","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2013.03.006_b0125","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1007\/s11095-008-9616-1","article-title":"Click chemistry, a powerful tool for pharmaceutical sciences","volume":"25","author":"Hein","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2013.03.006_b0130","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1021\/ja01192a022","article-title":"A new reaction of nitriles. I. Amides from alkenes and mononitriles","volume":"70","author":"Ritter","year":"1948","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejpb.2013.03.006_b0135","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajpath.2010.12.014","article-title":"Identification of novel markers for the diagnosis of malignant pleural mesothelioma","volume":"178","author":"Gueugnon","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejpb.2013.03.006_b0140","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/156800911797264761","article-title":"Pharmacological characterization of histone deacetylase inhibitor and tumor cell-growth inhibition properties of new benzofuranone compounds","volume":"11","author":"Blanquart","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"issue":"3","key":"10.1016\/j.ejpb.2013.03.006_b0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.embor.embor767","article-title":"Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells","volume":"4","author":"Boute","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejpb.2013.03.006_b0150","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s11095-005-5265-9","article-title":"Design, synthesis, and evaluation of original carriers for targeting vascular endothelial growth factor receptor interactions","volume":"22","author":"Gon\u00e7alves","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2013.03.006_b0155","doi-asserted-by":"crossref","first-page":"7328","DOI":"10.1021\/jo901410b","article-title":"Suppression of common-ion return by amines: a method to measure rates of fast SN1 reactions","volume":"19","author":"Streidl","year":"2009","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejpb.2013.03.006_b0160","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1021\/jo00196a009","article-title":"Energetics of carbonyl addition and elimination. Kinetic manifestations of acyl substituent effects in anilide hydrolysis","volume":"49","author":"Young","year":"1984","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejpb.2013.03.006_b0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1039\/cs9901900083","article-title":"The mechanisms of nucleophilic substitution in aliphatic compounds","volume":"19","author":"Katritzky","year":"1990","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejpb.2013.03.006_b0170","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1071\/CH10344","article-title":"Investigations into competitive cycloaddition\/cyclization or elimination from 1,1-dimethyl-propargylcarbamates of anilines","volume":"64","author":"Delatouche","year":"2011","journal-title":"Aust. J. Chem."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641113000933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641113000933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T06:42:48Z","timestamp":1562827368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641113000933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0939641113000933"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2013.03.006","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of pH responsive clickable prodrugs applied to histone deacetylase inhibitors: A new strategy for anticancer therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2013.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}